Describe two ways in which Pfizer has gained access to innovative drugs and other medical technologies. What challenges do you suppose the firm has faced in pursuing each of these strategies?

Describe two ways in which Pfizer has gained access to innovative drugs and other medical technologies. What challenges do you suppose the firm has faced in pursuing each of these strategies?
Pfizer has twice attempted to merge with another pharmaceutical company, and both times the mergers have failed. Why is Pfizer so eager to merge? Why did these attempts fail? What segments of the external environment have influenced this situation?
When Ian Read became the CEO in 2010, he restructured Pfizer into two segments: Established Products and Innovative Products. What type of structure is the firm now using? How will this move benefit the firm?
Pfizer and other big pharma companies have been harshly criticized for charging “exorbitant” prices for some of their drugs, but Pfizer says its prices are justified. Debate the issue, examining both viewpoints. Is this a smart pricing strategy or not? Be sure to support your response.